A detailed history of Israel Englander (Millennium Management LLC) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 11,447 shares of RANI stock, worth $16,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,447
Holding current value
$16,025
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.06 - $3.99 $23,580 - $45,673
11,447 New
11,447 $24,000
Q2 2023

Aug 14, 2023

BUY
$3.92 - $5.58 $230,860 - $328,622
58,893 Added 78.98%
133,461 $549,000
Q1 2023

May 15, 2023

BUY
$5.07 - $6.89 $7,219 - $9,811
1,424 Added 1.95%
74,568 $385,000
Q4 2022

Feb 14, 2023

SELL
$5.51 - $10.02 $88,104 - $160,219
-15,990 Reduced 17.94%
73,144 $432,000
Q3 2022

Nov 14, 2022

SELL
$8.23 - $12.4 $186,384 - $280,822
-22,647 Reduced 20.26%
89,134 $854,000

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $34.3M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.